Has Lailatullah Burgos received payments from drug or device companies?

Yes. Drug and device makers reported $4,780 in general payments to Lailatullah Burgos across 248 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lailatullah Burgos did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lailatullah Burgos come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lailatullah Burgos

Family · Lecanto, FLNPI 1285785428

Payments from drug & device makers

$4,780in general payments, 2019–2025

Across 248 payments — averaging $19.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$810
Alkermes, Inc.$642
Neurocrine Biosciences, Inc.$529
Johnson & Johnson$498
Vanda Pharmaceuticals Inc.$486
Otsuka America Pharmaceutical, Inc.$434
plus $1K from 16 others

What the payments were for

Food & beverage$4,73399%
Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	65	$810
Alkermes, Inc.	27	$642
Neurocrine Biosciences, Inc.	24	$529
Johnson & Johnson	29	$498
Vanda Pharmaceuticals Inc.	20	$486
Otsuka America Pharmaceutical, Inc.	17	$434
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	10	$309
Teva Pharmaceuticals USA, Inc.	16	$252
Indivior Inc.	11	$216
Sunovion Pharmaceuticals Inc.	7	$109
Axsome Therapeutics, Inc.	4	$81
Supernus Pharmaceuticals, Inc.	3	$73
E.r. Squibb & Sons, L.L.C.	3	$67
Gilead	2	$46
Acadia Pharmaceuticals Inc	1	$45
Lundbeck LLC	3	$44
Otsuka Pharmaceutical Development & Commercialization, Inc.	1	$31
Ironshore Pharmaceuticals Inc.	1	$28
Braeburn Inc.	1	$22
Takeda Pharmaceuticals U.S.A., Inc.	1	$20
Tempus AI, Inc	1	$19
Almatica Pharma LLC	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,780 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Quetiapine Fumarate ErQuetiapine Fumarate	17	$2,717
Ziprasidone Hcl	12	$765
Bupropion XlBupropion Hcl	11	$493
Doxepin Hcl	11	$415
Buspirone Hcl	16	$264
Quetiapine Fumarate	22	$231
Duloxetine Hcl	13	$213
Lamotrigine	25	$213
Trazodone Hcl	24	$154
Risperidone	12	$153
Lithium Carbonate	13	$78
Escitalopram Oxalate	13	$54
Clonazepam	12	$41

Paid to pharmacies, not to this prescriber.

Other family in Lecanto

John HuffakerVenice$8M
Stephanie MompointMiami$4.5M
Miguel TrujilloMiami Gardens$4.4M
Itsel Cardenas RamonMiami$1M
Lewis HarringtonTampa$954K
Adam StrosbergFort Lauderdale$859K
Danielle PharesFt Lauderdale$713K
David RodriguezHialeah$658K
Donna OrtizOrlando$417K
Patrick SzarazMiami$327K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →